ANI PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Ani Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2012 to Q2 2024.
  • Ani Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Ani Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $8.49M.
  • Ani Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $1.09M.
  • Ani Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was -$14.8M, a 9.77% decline from 2021.
  • Ani Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$13.5M, a 294% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.49M $0 +$996K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $7.5M $7.13M +$6.4M +882% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.09M -$208K +$1.28M +86% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$184K $1.57M +$5.19M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$5.38M -$996K +$2.9M +74.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$8.28M $726K +$6.49M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$14.8M -$1.49M +$5.23M +77.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$20M -$3.62M -$939K -35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$19.1M -$3.9M +$150K +3.71% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$19.2M -$5.77M -$5.76M -57570% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$13.5M -$6.72M -$7.97M -636% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$5.49M -$2.68M -$2.31M -623% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$3.17M -$4.05M -$2.6M -180% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$571K -$10K +$2.84M +99.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$3.41M $1.25M +$4.07M Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$7.48M -$371K -$435K -680% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$7.05M -$1.44M -$790K -121% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$6.26M -$2.85M -$3.32M -708% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$2.94M -$2.82M -$4.73M -247% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $1.79M $64K -$1.27M -95.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $3.06M -$653K -$1.38M -190% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $4.43M $469K -$123K -20.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $4.56M $1.91M +$15.9M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$11.3M $1.33M +$2.98M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$14.3M $726K -$543K -42.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$13.8M $592K +$1.12M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$14.9M -$14M -$14.5M -2768% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$384K -$1.65M +$847K +33.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$1.23M $1.27M +$2.5M Mar 31, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$3.73M -$523K +$1.02M +66% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$4.74M $524K -$101K -16.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$4.64M -$2.5M -$3.6M -328% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 -$1.04M -$1.23M -$3.32M -159% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 $2.28M -$1.54M -$4.08M -161% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 $6.36M $625K +$11.6M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$5.21M $1.1M -$447K -28.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$4.77M $2.09M +$2.23M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$6.99M $2.54M +$2.38M +1440% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$9.37M -$10.9M -$11M -10726% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 $1.68M $1.55M +$1.63M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $52K -$133K -$133K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $185K $165K +$165K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $20K $103K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 -$83K -$83.9K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $0 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q3 2012 $866* Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.